As part of upcoming India-US Cancer Dialogue, both countries are planning to focus on advancing knowledge in cancer genomics, developing new diagnostics, therapeutics etc.
Starting this week, Mumbai’s Tata Memorial Centre will offer ‘proton beam therapy’, which allows more targeted treatment of cancerous tumours and fewer side-effects.
Pharma giant Bristol Myers Squibb & partner 2seventy bio say they've successfully tested the treatment, which is aimed at stimulating patient’s immune system to act more efficiently.
Trastuzumab deruxtecan helped check cancer growth in even those with low levels of protein that cancer drugs target. Tumours didn't grow for at least 10 months, compared to average 5 in chemotherapy.
The National Family Health Survey 5 data revealed that India's cancer screening coverage also remains poor, with only 0.6% undergoing breast examination and 0.7% taking oral cavity test.
India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS